Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP106590E

Novus Biologicals™ Meckelin Antibody Blocking Peptide
SDP

Catalog No. NBP106590E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP106590E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP106590E Supplier Novus Biologicals™ Supplier No. NBP106590PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A peptide to Meckelin. Accession #: Q5HYA8. Source: Synthetic The Meckelin Blocking Peptide is derived from Synthetic. The Meckelin Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 91147
Species Human
Purity >75%
Accession Number Q5HYA8
Content And Storage Store at 4 C short term. Aliquot and store (at -20 C long term. Avoid freeze-thaw cycles.)
Formulation PBS, BSA 0,1 %
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-06590. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias meckel syndrome type 3 protein, Meckelin, MGC26979, TNEM67, transmembrane protein 67
Gene Symbol TMEM67
Molecular Weight (g/mol) M.W. (theoretical): 1.72 kDa
Product Type Meckelin
Quantity 0.05 mg
Regulatory Status RUO - research use only
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.